Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome?
Kidney Int
.
2004 Mar;65(3):1105-6.
doi: 10.1111/j.1523-1755.2004.00527.x.
Author
Mary Helen Foster
PMID:
14871432
DOI:
10.1111/j.1523-1755.2004.00527.x
No abstract available
Publication types
Comment
Editorial
Review
MeSH terms
AIDS-Associated Nephropathy / drug therapy*
AIDS-Associated Nephropathy / metabolism*
Animals
Antiretroviral Therapy, Highly Active*
HIV Protease Inhibitors / pharmacology*
Humans
Oxidative Stress / drug effects*
Substances
HIV Protease Inhibitors